HTG Molecular Diagnostics, Inc. (HTGMQ)
OTCMKTS: HTGMQ · Delayed Price · USD
0.0015
0.00 (0.00%)
Jul 19, 2024, 4:00 PM EDT - Market open
HTG Molecular Diagnostics Market Cap
HTG Molecular Diagnostics has a market cap or net worth of $3.32 thousand as of July 22, 2024. Its market cap has decreased by -99.93% in one year.
Market Cap
3.32K
Enterprise Value
n/a
1-Year Change
-99.93%
Ranking
n/a
Category
Stock Price
$0.00
Market Cap Chart
Since May 6, 2015, HTG Molecular Diagnostics's market cap has decreased from $92.70M to $3.32K, a decrease of -100.00%. That is a compound annual growth rate of -71.69%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 14, 2023 | 1.10M | -70.27% |
| Dec 30, 2022 | 3.70M | -90.98% |
| Dec 31, 2021 | 41.00M | 80.62% |
| Dec 31, 2020 | 22.70M | -44.23% |
| Dec 31, 2019 | 40.70M | -43.78% |
| Dec 31, 2018 | 72.40M | 185.04% |
| Dec 29, 2017 | 25.40M | 60.76% |
| Dec 30, 2016 | 15.80M | -46.98% |
| Dec 31, 2015 | 29.80M | -67.85% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly | 814.94B |
| Novo Nordisk | 579.91B |
| UnitedHealth Group | 520.32B |
| Johnson & Johnson | 372.29B |
| Merck & Co. | 318.55B |
| AbbVie | 304.29B |
| AstraZeneca | 244.04B |
| Novartis AG | 207.64B |